Kesimpta – Multiple Sclerosis – Sep Display Banners HCP Wallboard Extension – 22353

Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR) both decreased symptoms and improved emotional competencies among patients with MS, according to study findings published in Multiple...

Inflammation may be a modifiable aspect of long-term disability for patients with primary progressive MS (PPMS), according to results published in JAMA Neurology. Massimo Filippi, MD, and colleagues examined the impact of...

Studies have suggested that patients with MS have a greater susceptibility to COVID-19 infection as a result of the disease and/or the use of disease-modifying therapies (DMTs). For a study published in the Journal of Neurology,...

An increasing number of physicians are growing frustrated with patients who choose not to get their COVID-19 vaccinations. This leads to a dilemma for those physicians who would like to terminate their relationships with...

The CDC estimates 60% of US adults have a chronic disease, and 40% have two or more. It is the leading cause of death and disability and a driver of the nation’s more than $3.8 trillion in annual healthcare costs. Four main risk...